Antibiotic resistance as collateral damage: the tragedy of the commons in a two-disease setting
From MaRDI portal
(Redirected from Publication:494466)
Recommendations
- Harnessing intra-host strain competition to limit antibiotic resistance: mathematical model results
- Economics of antibiotic resistance: A theory of optimal use
- The economic dynamics of antibiotic efficacy under open access
- To treat or not to treat: The case of tuberculosis
- The population genetics of antibiotic resistance. II: Analytic theory for sustained populations of bacteria in a community of hosts
Cites work
- scientific article; zbMATH DE number 758785 (Why is no real title available?)
- A competitive exclusion principle for pathogen virulence
- A general approach for population games with application to vaccination
- Coinfection dynamics of two diseases in a single host population
- Epidemiologic interference of virus populations
- Mathematical analysis of a model for HIV-malaria co-infection
- Mathematical analysis of the transmission dynamics of HIV/TB coinfection in the presence of treatment
- Mathematical model for malaria and meningitis co-infection among children
- Modeling HIV/AIDS and tuberculosis coinfection
- Modeling TB and HIV co-infections
- Modeling infectious diseases in humans and animals
- Modeling the interaction between AIDS and tuberculosis
- Rapid emergence of co-colonization with community-acquired and hospital-acquired methicillin-resistant staphylococcus aureus strains in the hospital setting
- Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission
- The effects of human movement on the persistence of vector-borne diseases
Cited in
(6)- The straight and narrow: a game theory model of broad- and narrow-spectrum empiric antibiotic therapy
- Compartmental model diagrams as causal representations in relation to DAGs
- Coinfection dynamics of two diseases in a single host population
- A note on common infections and the non-antibiotic treatment option
- A refunding scheme to incentivize narrow-spectrum antibiotic development
- The economic dynamics of antibiotic efficacy under open access
This page was built for publication: Antibiotic resistance as collateral damage: the tragedy of the commons in a two-disease setting
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q494466)